Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

3-Hydroxypropionic acid may help treat hair loss by promoting hair growth in cells.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Skin aging reflects overall body aging and can indicate internal health conditions.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

Overexpressing Dsg3 in mice skin causes excessive cell growth and abnormal skin development.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Mechanical stimulation and new therapies show promise for hair regrowth.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Homeopathic treatment improved symptoms and thyroid levels in a woman with subclinical hypothyroidism.

A 5% minoxidil spray could effectively treat male baldness with fewer side effects and better patient comfort.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Mutant mice help researchers understand hair growth and related genetic factors.

The method accurately measures steroid hormones in hair to study hormone dynamics related to hair loss.

Versican, a protein, is less present in thinning hair follicles and this decrease might contribute to common hair loss in men.

Deleting the CDSN gene causes severe skin and hair problems, leading to death.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

SIRT7 protein is crucial for starting hair growth in mice.

Climate-related nutritional stress may cause hair loss in juvenile male Guadalupe fur seals.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.